BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

702 related articles for article (PubMed ID: 12397878)

  • 1. Neuroleptic malignant syndrome due to olanzapine.
    Hall KL; Taylor WH; Ware MR
    Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuroleptic malignant syndrome: case report with recurrence associated with the use of olanzapine].
    Hanel RA; Sandmann MC; Kranich M; De Bittencourt PR
    Arq Neuropsiquiatr; 1998 Dec; 56(4):833-7. PubMed ID: 10029891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine induced neuroleptic malignant syndrome--a case review.
    Kogoj A; Velikonja I
    Hum Psychopharmacol; 2003 Jun; 18(4):301-9. PubMed ID: 12766935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroleptic malignant syndrome after treatment with olanzapine].
    Emborg C
    Ugeskr Laeger; 1999 Mar; 161(10):1424-5. PubMed ID: 10085753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical neuroleptic malignant syndrome associated with olanzapine.
    Reeves RR; Torres RA; Liberto V; Hart RH
    Pharmacotherapy; 2002 May; 22(5):641-4. PubMed ID: 12013364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuroleptic malignant syndrome in a patient treated with olanzapine].
    Horni G; Meirik K; Lund MB
    Tidsskr Nor Laegeforen; 2003 Oct; 123(20):2867-9. PubMed ID: 14600711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome associated with olanzapine therapy: a case report.
    Stanfield SC; Privette T
    J Emerg Med; 2000 Nov; 19(4):355-7. PubMed ID: 11074330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome during olanzapine and levomepromazine treatment.
    Järventausta K; Leinonen E
    Acta Psychiatr Scand; 2000 Sep; 102(3):231-3. PubMed ID: 11008860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome associated with olanzapine.
    Johnson V; Bruxner G
    Aust N Z J Psychiatry; 1998 Dec; 32(6):884-6. PubMed ID: 10084355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome associated with olanzapine.
    Filice GA; McDougall BC; Ercan-Fang N; Billington CJ
    Ann Pharmacother; 1998 Nov; 32(11):1158-9. PubMed ID: 9825080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.
    Aboraya A; Schumacher J; Abdalla E; LePage J; McGhee M; Butcher D; Griffin H; Shahda M
    W V Med J; 2002; 98(2):63-5. PubMed ID: 12048741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Life threatening neuroleptic malignant syndrome due to olanzapine].
    Kopf A; Köster J; Schulz A; Krömker H; Becker T
    Psychiatr Prax; 2003 Jul; 30(5):279-82. PubMed ID: 12872187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome in an adolescent receiving olanzapine-lithium combination therapy.
    Berry N; Pradhan S; Sagar R; Gupta SK
    Pharmacotherapy; 2003 Feb; 23(2):255-9. PubMed ID: 12587815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine-associated neuroleptic malignant syndrome.
    Norgard NB; Stark JE
    Pharmacotherapy; 2006 Aug; 26(8):1180-2. PubMed ID: 16863495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical neuroleptic malignant syndrome caused by olanzapine.
    Nielsen J; Bruhn AM
    Acta Psychiatr Scand; 2005 Sep; 112(3):238-40; discussion 240. PubMed ID: 16095481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case report of neuroleptic malignant syndrome without fever in a patient given aripiprazole.
    Rodriguez OP; Dowell MS
    J Okla State Med Assoc; 2006; 99(7):435-8. PubMed ID: 17017330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine-associated neuroleptic malignant syndrome.
    Kontaxakis VP; Havaki-Kontaxaki BJ; Christodoulou NG; Paplos KG
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jun; 26(5):897-902. PubMed ID: 12369263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management.
    Perry PJ; Wilborn CA
    Ann Clin Psychiatry; 2012 May; 24(2):155-62. PubMed ID: 22563571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuroleptic malignant syndrome. Case reports].
    Berardi D; Troia M; Veronesi L; Ferrari G
    Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.